The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review

Journal of Affective Disorders

Volumn 203, Issue , 2016, Pages 364-373

  Van Den Ameele, Seline ^a,b   Van Diermen, Linda ^a,b   Staels, Willem ^c,d,e   Coppens, Violette ^a,b   Dumont, Glenn ^f   Sabbe, Bernard ^a,b   Morrens, Manuel ^a,g  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Psychiatric Hospital Duffel   (Belgium)

^c DIABETES RESEARCH CENTER   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g Psychiatric Hospital Broeders Alexianen   (Belgium)

Author keywords

Bipolar disorder; Cytokines; Inflammation; Lithium; Mood stabilizing drugs; Systematicreview

Indexed keywords

ANTICONVULSIVE AGENT; CYTOKINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROIC ACID; LAMOTRIGINE; TRANQUILIZER; TRIAZINE DERIVATIVE;

BIPOLAR DISORDER; BLOOD LEVEL; DATA BASE; DATA EXTRACTION; EX VIVO STUDY; HUMAN; MONOTHERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; AFFECT; BLOOD; DRUG EFFECTS; FEMALE;

AFFECT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CYTOKINES; FEMALE; HUMANS; LITHIUM; TRIAZINES; VALPROIC ACID;

EID: 84975886594     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.06.016     Document Type: Review

References (83)

1. S. Agrawal, S. Gollapudi, S. Gupta, and A. Agrawal Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to lithium chloride Exp. Gerontol. 48 2013 1285 1292
2. I.G. Barbosa, R.B. Huguet, V.A. Mendonca, L.P. Sousa, F.S. Neves, M.E. Bauer, and A.L. Teixeira Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder Eur. Arch. psychiatry Clin. Neurosci. 261 2011 139 143
3. M. Bauer, T. Glenn, M. Alda, K. Sagduyu, W. Marsh, P. Grof, R. Munoz, E. Severus, P. Ritter, and P.C. Whybrow Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data Int. J. bipolar Disord. 1 2013 5
4. K. Becking, B.C. Haarman, R.F. van der Lek, L. Grosse, W.A. Nolen, S. Claes, H.A. Drexhage, and R.A. Schoevers Inflammatory monocyte gene expression: trait or state marker in bipolar disorder? Int. J. bipolar Disord. 3 2015 20
5. W. Beumer, S.M. Gibney, R.C. Drexhage, L. Pont-Lezica, J. Doorduin, H.C. Klein, J. Steiner, T.J. Connor, A. Harkin, M.A. Versnel, and H.A. Drexhage The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes J. Leukoc. Biol. 92 2012 959 975
6. F. Boufidou, C. Nikolaou, B. Alevizos, I.A. Liappas, and G.N. Christodoulou Cytokine production in bipolar affective disorder patients under lithium treatment J. Affect. Disord. 82 2004 309 313
7. M.N. Breunis, R.W. Kupka, W.A. Nolen, T. Suppes, K.D. Denicoff, G.S. Leverich, R.M. Post, and H.A. Drexhage High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder Biol. psychiatry 53 2003 157 165
8. J. Carmen, K. Okafor, and E. Ike The effects of lithium therapy on leukocytes: a 1-year follow-up study J. Natl. Med. Assoc. 85 1993 301 303
9. T. Cetin, S. Guloksuz, E.A. Cetin, S.B. Gazioglu, G. Deniz, E.T. Oral, and J. van Os Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms BMC Psychiatry 12 2012 158
10. A. Cipriani, C. Barbui, G. Salanti, J. Rendell, R. Brown, S. Stockton, M. Purgato, L.M. Spineli, G.M. Goodwin, and J.R. Geddes Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet 378 2011 1306 1315
11. A.B. Cunha, A.C. Andreazza, F.A. Gomes, B.N. Frey, L.E. da Silveira, C.A. Goncalves, and F. Kapczinski Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder Eur. Arch. Psychiatry Clin. Neurosci. 258 2008 300 304
12. F. Dickerson, C. Stallings, A. Origoni, J. Boronow, and R. Yolken Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 2007 952 955
13. A. Diez-Ruiz, G.P. Tilz, R. Zangerle, G. Baier-Bitterlich, H. Wachter, and D. Fuchs Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis Eur. J. Haematol. 54 1995 1 8
14. R.C. Drexhage, E.M. Knijff, R.C. Padmos, L. Heul-Nieuwenhuijzen, W. Beumer, M.A. Versnel, and H.A. Drexhage The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder Expert Rev. Neurother. 10 2010 59 76
15. L. Drzyzga, E. Obuchowicz, A. Marcinowska, and Z.S. Herman Cytokines in schizophrenia and the effects of antipsychotic drugs Brain Behav. Immun. 20 2006 532 545
16. J.G. Fiedorowicz, A.R. Prossin, C.P. Johnson, G.E. Christensen, V.A. Magnotta, and J.A. Wemmie Peripheral inflammation during abnormal mood states in bipolar I disorder J. Affect. Disord. 187 2015 172 178
17. J.R. Geddes, and D.J. Miklowitz Treatment of bipolar disorder Lancet 381 2013 1672 1682
18. B.I. Goldstein, D.E. Kemp, J.K. Soczynska, and R.S. McIntyre Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature J. Clin. Psychiatry 70 2009 1078 1090
19. S. Guloksuz, K. Altinbas, E. Aktas Cetin, G. Kenis, S. Bilgic Gazioglu, G. Deniz, E.T. Oral, and J. van Os Evidence for an association between tumor necrosis factor-alpha levels and lithium response J. Affect. Disord. 143 2012 148 152
20. S. Guloksuz, E.A. Cetin, T. Cetin, G. Deniz, E.T. Oral, and D.J. Nutt Cytokine levels in euthymic bipolar patients J. Affect. Disord. 126 2010 458 462
21. M. Haack, D. Hinze-Selch, T. Fenzel, T. Kraus, M. Kuhn, A. Schuld, and T. Pollmacher Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J. Psychiatr. Res. 33 1999 407 418
22. B.C. Haarman, R.F. Riemersma-Van der Lek, H. Burger, M. Netkova, R.C. Drexhage, F. Bootsman, E. Mesman, M.H. Hillegers, A.T. Spijker, E. Hoencamp, H.A. Drexhage, and W.A. Nolen Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder - towards a better understanding of psychoimmunological interactions Bipolar Disord. 16 2014 137 150
23. B.H. Harvey, C.L. Meyer, V.S. Gallichio, and H.K. Manji Lithium salts in AIDS and AIDS-related dementia Psychopharmacol. Bull. 36 2002 5 26
24. H. Himmerich, S. Bartsch, H. Hamer, R. Mergl, J. Schonherr, C. Petersein, A. Munzer, K.C. Kirkby, K. Bauer, and U. Sack Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro J. Psychiatr. Res. 47 2013 1751 1759
25. H. Himmerich, S. Bartsch, H. Hamer, R. Mergl, J. Schonherr, C. Petersein, A. Munzer, K.C. Kirkby, K. Bauer, and U. Sack Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro Oxid. Med. Cell. Longev. 2014 2014 806162
26. H. Himmerich, J. Schonherr, S. Fulda, A.J. Sheldrick, K. Bauer, and U. Sack Impact of antipsychotics on cytokine production in-vitro J. Psychiatr. Res. 45 2011 1358 1365
27. M. Hornig, D.B. Goodman, M. Kamoun, and J.D. Amsterdam Positive and negative acute phase proteins in affective subtypes J. Affect. Disord. 49 1998 9 18
28. T. Ichiyama, K. Okada, J.M. Lipton, T. Matsubara, T. Hayashi, and S. Furukawa Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB Brain Res. 857 2000 246 251
29. R.S. Jope Anti-bipolar therapy: mechanism of action of lithium Mol. psychiatry 4 1999 117 128
30. Y.K. Kim, H.G. Jung, A.M. Myint, H. Kim, and S.H. Park Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder J. Affect. Disord. 104 2007 91 95
31. Y.K. Kim, A.M. Myint, B.H. Lee, C.S. Han, S.W. Lee, B.E. Leonard, and H.W. Steinbusch T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients Psychiatry Res. 129 2004 267 272
32. Y.K. Kim, I.B. Suh, H. Kim, C.S. Han, C.S. Lim, S.H. Choi, and J. Licinio The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs Mol. Psychiatry 7 2002 1107 1114
33. E.S. Kleinerman, R.D. Knowles, M.B. Blick, and L.A. Zwelling Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin J. Leukoc. Biol. 46 1989 484 492
34. E.M. Knijff, M.N. Breunis, R.W. Kupka, H.J. de Wit, C. Ruwhof, G.W. Akkerhuis, W.A. Nolen, and H.A. Drexhage An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment Bipolar Disord. 9 2007 743 753
35. Z. Kronfol, and D.G. Remick Cytokines and the brain: implications for clinical psychiatry Am. J. Psychiatry 157 2000 683 694
36. S.Y. Lee, S.L. Chen, Y.H. Chang, P.S. Chen, S.Y. Huang, N.S. Tzeng, Y.S. Wang, L.J. Wang, I.H. Lee, T.Y. Wang, T.L. Yeh, Y.K. Yang, J.S. Hong, and R.B. Lu The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial J. Clin. Psychopharmacol. 34 2014 337 343
37. S.X. Leng, J.E. McElhaney, J.D. Walston, D. Xie, N.S. Fedarko, and G.A. Kuchel ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. The journals of gerontology Ser. A Biol. Sci. Med. Sci. 63 2008 879 884
38. B. Levy, and E. Manove Functional outcome in bipolar disorder: the big picture Depress. Res. Treat. 2012 2012 949248
39. H. Li, W. Hong, C. Zhang, Z. Wu, Z. Wang, C. Yuan, Z. Li, J. Huang, Z. Lin, and Y. Fang IL-23 and TGF-beta1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode J. Affect. Disord. 174 2015 361 366
40. W. Liao, J.-X. Lin, and W.J. Leonard IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation Curr. Opin. Immunol. 23 2011 598 604
41. J. Lieb Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate Med. Hypotheses 7 1981 885 890
42. H.C. Liu, Y.Y. Yang, Y.M. Chou, K.P. Chen, W.W. Shen, and S.J. Leu Immunologic variables in acute mania of bipolar disorder J. Neuroimmunol. 150 2004 116 122
43. M. Maes, E. Bosmans, J. Calabrese, R. Smith, and H.Y. Meltzer Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers J. Psychiatr. Res. 29 1995 141 152
44. M. Maes, J. Delange, R. Ranjan, H.Y. Meltzer, R. Desnyder, W. Cooremans, and S. Scharpe Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs Psychiatry Res. 66 1997 1 11
45. M. Maes, R. Smith, and S. Scharpe The monocyte-T-lymphocyte hypothesis of major depression Psychoneuroendocrinology 20 1995 111 116
46. M. Maes, C. Song, A.H. Lin, R. Pioli, G. Kenis, M. Kubera, and E. Bosmans In vitro immunoregulatory effects of lithium in healthy volunteers Psychopharmacology 143 1999 401 407
47. V. Maletic, and C. Raison Integrated neurobiology of bipolar disorder Front. Psychiatry 5 2014 98
48. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol. Psychiatry 65 2009 732 741
49. B.J. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects Biol. Psychiatry 70 2011 663 671
50. J. Mlodzikowska-Albrecht, B. Steinborn, and M. Zarowski Cytokines, epilepsy and epileptic drugs-is there a mutual influence? Pharmacol. Rep.: PR 59 2007 129 138
51. A. Modabbernia, S. Taslimi, E. Brietzke, and M. Ashrafi Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies Biol. Psychiatry 74 2013 15 25
52. D. Moher, L. Shamseer, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, and L.A. Stewart Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Syst. Rev. 4 2015 1
53. R.J. Moots, Z. Al-Saffar, D. Hutchinson, S.P. Golding, S.P. Young, P.A. Bacon, and P.J. McLaughlin Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines Ann. Rheum. Dis. 58 1999 585 587
54. K. Munkholm, J.V. Brauner, L.V. Kessing, and M. Vinberg Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis J. Psychiatr. Res. 47 2013 1119 1133
55. M.F. O'Connor, J.E. Bower, H.J. Cho, J.D. Creswell, S. Dimitrov, M.E. Hamby, M.A. Hoyt, J.L. Martin, T.F. Robles, E.K. Sloan, K.S. Thomas, and M.R. Irwin To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers Brain Behav. Immun. 23 2009 887 897
56. A. Ortiz-Dominguez, M.E. Hernandez, C. Berlanga, D. Gutierrez-Mora, J. Moreno, G. Heinze, and L. Pavon Immune variations in bipolar disorder: phasic differences Bipolar Disord. 9 2007 596 602
57. R.C. Padmos, M.H. Hillegers, E.M. Knijff, R. Vonk, A. Bouvy, F.J. Staal, D. de Ridder, R.W. Kupka, W.A. Nolen, and H.A. Drexhage A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes Arch. Gen. Psychiatry 65 2008 395 407
58. C. Petersein, U. Sack, R. Mergl, J. Schonherr, F.M. Schmidt, N. Lichtblau, K.C. Kirkby, K. Bauer, and H. Himmerich Impact of lithium alone and in combination with antidepressants on cytokine production in vitro J. neural Transm. 122 2015 109 122
59. M. Petrini, and A. Azzara Lithium in the treatment of neutropenia Curr. Opin. Hematol. 19 2012 52 57
60. M.L. Phillips, and D.J. Kupfer Bipolar disorder diagnosis: challenges and future directions Lancet 381 2013 1663 1671
61. M.H. Rapaport Immune parameters in euthymic bipolar patients and normal volunteers J. Affect. Disord. 32 1994 149 156
62. M.H. Rapaport, L. Guylai, and P. Whybrow Immune parameters in rapid cycling bipolar patients before and after lithium treatment J. Psychiatr. Res. 33 1999 335 340
63. M.H. Rapaport, and H.K. Manji The effects of lithium on ex vivo cytokine production Biol. Psychiatry 50 2001 217 224
64. A. Remlinger-Molenda, P. Wojciak, M. Michalak, J. Karczewski, and J.K. Rybakowski Selected cytokine profiles during remission in bipolar patients Neuropsychobiology 66 2012 193 198
65. J.D. Rosenblat, D.S. Cha, R.B. Mansur, and R.S. McIntyre Inflamed moods: a review of the interactions between inflammation and mood disorders Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2014
66. A.G. Shabgah, E. Fattahi, and F.Z. Shahneh Interleukin-17 in human inflammatory diseases Postepy Dermatol. Alergol. 31 2014 256 261
67. G.R. Skinner, C. Hartley, A. Buchan, L. Harper, and P. Gallimore The effect of lithium chloride on the replication of herpes simplex virus Med. Microbiol. Immunol. 168 1980 139 148
68. A. Sluzewska, M. Sobieska, and J.K. Rybakowski Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression Neuropsychobiology 35 1997 123 127
69. K. Soares-Weiser, Y. Bravo Vergel, S. Beynon, G. Dunn, M. Barbieri, S. Duffy, J. Geddes, S. Gilbody, S. Palmer, and N. Woolacott A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder Health Technol. Assess. 11 2007 iii-iv, ix-206
70. L. Stertz, P.V. Magalhaes, and F. Kapczinski Is bipolar disorder an inflammatory condition? The relevance of microglial activation Curr. Opin. Psychiatry 26 2013 19 26
71. S. Suda, K. Katsura, T. Kanamaru, M. Saito, and Y. Katayama Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation Eur. J. Pharmacol. 707 2013 26 31
72. H. Sugino, T. Futamura, Y. Mitsumoto, K. Maeda, and Y. Marunaka Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry 33 2009 303 307
73. A.L. Teixeira, R.T. de Souza, M.V. Zanetti, A.R. Brunoni, G.F. Busatto, C.A. Zarate Jr., W.F. Gattaz, and R. Machado-Vieira Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment Hum. Psychopharmacol. 30 2015 52 56
74. V. Tourjman, E. Kouassi, M.E. Koue, M. Rocchetti, S. Fortin-Fournier, P. Fusar-Poli, and S. Potvin Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis Schizophr. Res. 151 2013 43 47
75. S.Y. Tsai, H.C. Lee, C.C. Chen, and C.H. Lee Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission J. Psychiatr. Res. 37 2003 229 235
76. S.Y. Tsai, Y.Y. Yang, C.J. Kuo, C.C. Chen, and S.J. Leu Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania J. Affect. Disord. 64 2001 185 193
77. V. Uyanik, C. Tuglu, Y. Gorgulu, H. Kunduracilar, and M. Uyanik Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment Psychiatry Res. 228 2015 386 392
78. S. Watanabe, J. Iga, A. Nishi, S. Numata, M. Kinoshita, K. Kikuchi, M. Nakataki, and T. Ohmori Microarray analysis of global gene expression in leukocytes following lithium treatment Hum. Psychopharmacol. 29 2014 190 198
79. J. Wolf, S. Rose-John, and C. Garbers Interleukin-6 and its receptors: a highly regulated and dynamic system Cytokine 2014
80. Z. Xia, J.W. DePierre, and L. Nassberger Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells Immunopharmacology 34 1996 27 37
81. S. Yamamoto, N. Ohta, A. Matsumoto, Y. Horiguchi, M. Koide, and Y. Fujino Haloperidol Suppresses NF-kappaB to Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Response in RAW 264 Cells. Medical science monitor Int. Med. J. Exp. Clin. Res. 22 2016 367 372
82. L.N. Yatham, S.H. Kennedy, S.V. Parikh, A. Schaffer, S. Beaulieu, M. Alda, C. O'Donovan, G. Macqueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, R. Milev, D.J. Bond, B.N. Frey, B.I. Goldstein, B. Lafer, B. Birmaher, K. Ha, W.A. Nolen, and M. Berk Canadian Network for Mood and Anxiety Treatments (CANMA)T) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update Bipolar Disord. 15 2013 1 44
83. X. Zhou, M.S. Fragala, J.E. McElhaney, and G.A. Kuchel Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research Curr. Opin. Clin. Nutr. Metab. Care 13 2010 541 547